Market News & Trends
Protagonist Therapeutics Raises $14 Million
Protagonist Therapeutics, Inc. recently announced the completion of a $14-million Series B venture financing. The financing, led by new investor Johnson & Johnson Development Corporation…
Fuse Science Announces Major Advancements in Delivery of APIs
Fuse Science, Inc. recently announced their Round II Research results have shown their proprietary delivery technology has successfully delivered therapeutic doses of varying-size compounds directly…
Valeritas Closes $100 Million Financing
Valeritas recently announced they have closed a structured debt financing with Capital Royalty L.P., which provides Valeritas with up to $100 million to further support…
Ophthotech Raises $175 Million to Finance Pivotal Phase III Program
Ophthotech Corporation today recently announced it has raised $175 million to finance a global Phase III clinical program of its lead compound Fovista, an anti-platelet-derived…
GlaxoSmithKline Buys Okairos for $324 Million
GlaxoSmithKline (GSK) recently announced it has acquired Okairos AG (Okairos), a specialist developer of vaccine platform technologies for approximately $325 million in cash. Swiss-based Okairos,…
UPM Pharmaceuticals Purchases Pfizer Commercial Manufacturing Site
UPM Pharmaceuticals, a Baltimore, MD-based drug development and contract manufacturer, recently announced it will be acquiring the 500,000-sq-foot commercial manufacturing facility that Pfizer Inc. (PFE)…
AstraZeneca to Acquire Omthera Pharmaceuticals
AstraZeneca recently announced it has entered into a definitive agreement to acquire Omthera Pharmaceuticals, a specialty pharmaceutical company based in Princeton, NJ, focused on the…
Valeant Pharmaceuticals to Acquire Company for $8.7 Billion
Valeant Pharmaceuticals International, Inc. and Bausch + Lomb Holdings Incorporated, the global eye health company, recently announced they have entered into a definitive agreement under…
Integral BioSystems to Offer Ophthalmic Formulations for Eye Therapies
Integral BioSystems LLC is developing and will offer for license its novel, platform front-of-the-eye and back-of-the-eye ophthalmic therapeutic delivery systems, OcuSurf and EySite. Integral BioSystems’…
ApoCell Announces Delivery of First Prototypes of ApoStream CTC Isolation Technology
ApoCell, Inc. recently announced that the first prototypes of its ApoStream circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including…
MultiCell Technologies Files Patent Application to Achieve Targeted Tumor Cell Death
MultiCell Technologies, Inc. recently announced the filing of a US patent application concerning methods and formulations to achieve targeted tumor cell death. MCT-485 is a…
RBCC May Enter $142-Billion Drug Delivery Market
As part of the company’s push to carve out a share of the $142-billion US drug delivery market, Rainbow Coral Corp. opened talks this week…
J&J Expects More Than 10 NDAs
Johnson & Johnson recently announced it is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval…
Catalent Applied Drug Delivery Institute Announces Winners of Academic Competition
The academic competition aims to identify emerging scientific talent, foster drug delivery education, and reward academic excellence. Winners were chosen from leading US and European…
Novozymes’s Recombinant Human Albumin Helps Innovative Dry Eye Therapy
Novozymes Biopharma recently announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA. Designed…
AmerisourceBergen Corporation Completes $308-Million Divestiture
Frazier Healthcare and Packaging Coordinators, Inc. recently announced it has completed the acquisition of pharmaceutical packager AndersonBrecon from its parent company AmerisourceBergen Corporation. AndersonBrecon will…
Theravance & Elan Sign $1-Billion Agreement
Theravance, Inc. and Elan Corporation, plc recently announced they have entered into a royalty participation agreement wherein Elan will purchase a participation interest in potential…
Arbor Pharmaceuticals Announces FDA Approval
Arbor Pharmaceuticals recently announced that the US FDA has approved its New Drug Application (NDA) for Nymalize (nimodipine) oral solution. Nymalize was previously granted Orphan…
Cempra & Toyama Sign $70-Million License & Development Agreement
Cempra, Inc. recently announced the signing of an exclusive license and development agreement for solithromycin with Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings…
Bend Research Expands Analytical Sciences & Capacity
Bend Research Inc. recently announced it has expanded its Good Manufacturing Practice (GMP) analytical capabilities and capacity for pharmaceutical development. Coupled with the company’s existing…
